|
Tuesday, March 25 — 8:00 AM — Marriott Salon 2
Click on the numbers in parentheses to display abstracts.
Section B - GENITOURINARY PATHOLOGY
Chaired by: John Eble and Wael Sakr
| 8:00 |
Detection of Loss of 2 or More of Chromosomes 1, 2, 6, 10, and 17 by Fluorescence In Situ Hybridization Effectively Distinguishes Eosinophilic Chromophobe Renal Cell Carcinoma from Renal Oncocytoma
(650)
M Brunelli, JN Eble, S Zhang, G Martignoni, B Delahunt, F Bonetti, L Cheng
Indiana University, Indianapolis, IN; Universita di Verona, Verona, Italy; Wellington Medical School, Wellington, New Zealand
|
| 8:15 |
The Value of Immunohistochemistry in the Diagnosis of Epthelial Renal Neoplasms with Pink Cytoplasm
(645)
TA Bismar, M Che, WA Sakr, DJ Grignon
Harper University Hospital, The Karmanos Cancer Institute and Wayne State University, Detroit, MI
|
| 8:30 |
Chromophobe Renal Cell Carcinoma: A Clinicopathologic Study of 100 Cases
(735)
G Martignoni, JN Eble, M Brunelli, L Cheng, M Pea, B Delahunt
Indiana University, Indianapolis, IN; Universita di Verona, Verona, Italy; Wellington Medical School, Wellington, New Zealand
|
| 8:45 |
Characterization of Minute Adenocarcinomas of the Prostate at Radical Prostatectomy (RP)
(794)
A Truskinovsky, H Sanderson, JI Epstein
The Johns Hopkins Hospital, Baltimore, MD
|
| 9:00 |
Clinicopathological Characterstics of Patients Treated by Radical Prostatectomy (RP) Following the Diagnosis of Prostate Cancer (PCA) of a Single, Less Than 1 mm Focus in One Core Biopsy (Bx)
(765)
W Sakr, M Che, K Kolizeras, D Grignon
Harper University Hospital, Karmanos Cancer Institute & Wayne State University, Detroit, MI
|
| 9:15 |
Minimal Prostate Cancer with Ten-Core Prostate Biopsy: Correlation with Radical Prostatectomy (RP)
(791)
K Trpkov, J Tsui, A Yilmaz
Rockyview Hospital, Calgary, AB, Canada
|
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION III
|
| 11:00 |
Molecular Markers for Predicting Biochemical Recurrence in Men with Clinically Localized Prostate Cancer: A Multiplex Analysis Using High-Density Tissue Microarrays
(757)
DR Rhodes, MG Sanda, AM Chinnaiyan, MA Rubin
University of Michigan School of Medicine, Ann Arbor, MI
|
| 11:15 |
Alpha-methylacyl-CoA Racemase as a Molecular Marker for Papillary Renal Cell Carcinoma
(790)
MS Tretiakova, S Sahoo, BT Teh, T Krausz, XJ Yang
The University of Chicago, Chicago, IL; Van Andel Research Institute, Grand Rapids, MI
|
| 11:30 |
Expression & Diagnostic Utility of Alpha-Methylacyl-Coa-Racemase (AMACR) in Foamy Gland Prostate Cancer (FGPca) & Pseudohyperplastic Prostate Cancer (PSPca)
(808)
M Zhou, Z Jiang, JI Epstein
The Johns Hopkins Medical Institutions, Baltimore, MD; University of Massachusetts Medical School, Worchester, MA
|
| 11:45 |
Utility of Immunohistochemistry for Alpha-Methylacyl-Coa Racemase (AMACR) in Distinguishing Atrophic Prostate Cancer from Benign Atrophy
(674)
MA Farinola, JI Epstein
The Johns Hopkins Hospital, Baltimore, MD
|
|
|
